Novellia raises $18M for patient-powered real-world data in pharma research

Novellia is another missed healthcare funding story. The company says it raised an $18 million Series A led by Spark Capital, with Khosla Ventures, Acrew Capital, Bling Capital, and TMV participating, bringing total funding to $28 million. Novellia's model is to build real-world data from information patients choose to contribute to medical research, while giving patients a free tool to access and organize their full health history across providers. The company frames the target as pharma's expensive patient-data problem. This is medium-confidence because it is a press release, but it is relevant because AI in drug development increasingly depends on consented, longitudinal patient datasets rather than only literature or molecular data.

Key details: June 2, 2026, $18 million Series A, Novellia, Spark Capital, Khosla Ventures, Acrew Capital, Bling Capital, TMV.

Continue swiping for more AI Brief stories.